(0 items)
Small Medium Large | Print-Friendly Version of this Page  | Email this Page to a Friend
Skip Navigation Links
Press Releases
Hot Topics
Statements
Comments
Correspondence
White Papers
Contact Public Relations
AABB > Press Room > Press Releases

For Immediate Release
September 21, 2011 
Jennifer Garfinkel
+1.301.215.6526
publicrelations@aabb.org
Contact:
 

 Transfusion Medicine and Cellular Therapies Professionals to Gather in San Diego to Discuss Latest Developments at AABB Annual Meeting and CTTXPO 

MEDIA ADVISORY
WHEN: Saturday, October 22 - Tuesday, October 25, 2011
   
WHERE: San Diego Convention Center
111 West Harbor Drive
San Diego, Calif., USA


Educational programs and discussions will include:

Establishment Changes: Mergers, Acquisitions and Affiliations (9216-LMT)

Over the past several years, the blood banking community has been moving along a never-before-seen path, and along the way there has been a lot of fear and uncertainty. The community is responding to the advent of supply chain contracts and health-care reform legislation. Adjustments have been made in regards to manufacturing, increases in automation, decreases in the demand for blood, decreases in revenues, and increases in the level of competition that have not been seen historically. In this session, speakers from various organizations will discuss the regulatory requirements needed to move forward with establishment changes, the underlying drivers behind some of the joint agreements, the process used to develop the plans, and some specific challenges and benefits that have resulted from the endeavors.

Biovigilance Updates and Information You Can Use (9230-TC)

This session will include an overview of U.S. biovigilance activities to date and those in development and an opportunity to hear reports from the experiences of individual hospitals and blood centers that have implemented hemovigilance locally.

Bench to Bedside: Tales of Novel Therapies (9318-TC-CT)

This session will present the development of four exciting cell therapy applications, including use of embryonic stem cells for neuroregeneration and immunotherapies for cancer. For each cell therapy application, the speaker will discuss the various stages of development from research studies to clinical trial. Aspects such as funding, regulatory and administrative hurdles as ideas are moved from preclinical models to the bedside will be discussed.

Blood Management Program 101(9417-LMT-PBM)

The goal of a patient blood management program is to optimize patient outcomes with strategies that reduce or avoid allogeneic transfusions and ensure the appropriateness of administrating blood components and products when needed. Hospitals and blood centers are becoming increasingly aware of the benefits of patient blood management and blood conservation programs in improving patient care, managing scarce resources, and reducing financial costs associated with blood transfusion. Speakers will share their experiences, including successes and challenges with implementing a patient blood management program.

Additional Highlights:

  • Breakfast with Hal Broxmeyer, PhD, a founder of the field of cord blood stem cell transplantation
  • Opening Session featuring Dr. Bob Arnot, leading medical expert, journalist, and the face of Google Health
  • CEO Summit presentations, "To ACO or Not to ACO," "The Future of 'Community'" and "Healthcare is in the Eyes of the Beholder"
  • CTTXPO Exhibit Hall opening on Saturday and featuring more than 200 exhibiting companies

To receive a complimentary press registration, please call +1.301.215.6526, or email publicrelations@aabb.org. For more information about AABB's Annual Meeting, visit: www.aabb.org > Meetings and Events > Annual Meeting and CTTXPO.

###

Home  |  Site Map  | AABB © 2014. All rights reserved. |  Privacy Statement  |  Terms of Use